PFM Health Sciences’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-104,323
| Closed | -$1.06M | – | 67 |
|
|
2025
Q1 | $1.06M | Hold |
104,323
| – | – | 0.08% | 57 |
|
|
2024
Q4 | $1.65M | Buy |
104,323
+3,273
| +3% | +$51.8K | 0.1% | 66 |
|
|
2024
Q3 | $5.87M | Buy |
101,050
+67,695
| +203% | +$3.93M | 0.33% | 47 |
|
|
2024
Q2 | $1.52M | Buy |
+33,355
| New | +$1.52M | 0.08% | 68 |
|
|
2023
Q3 | – | Sell |
-20,350
| Closed | -$818K | – | 76 |
|
|
2023
Q2 | $818K | Hold |
20,350
| – | – | 0.03% | 77 |
|
|
2023
Q1 | $869K | Buy |
20,350
+4,351
| +27% | +$186K | 0.04% | 72 |
|
|
2022
Q4 | $768K | Buy |
+15,999
| New | +$768K | 0.03% | 71 |
|